Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spannbauer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
World Journal of Hepatology|December 17, 2010
Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenibChristoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, et al.
Clinical Colorectal Cancer|May 26, 2011
Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunctionChristoph Roderburg, Nicole do O, Roland Fuchs, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|September 18, 2007
Regenerative capacity differs between micro- and macrovesicular hepatic steatosisAgnieszka Oleszczuk, Michael Spannbauer, Andrea Tannapfel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
World Journal of Hepatology|December 17, 2010
Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenibChristoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, et al.
Clinical Colorectal Cancer|May 26, 2011
Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunctionChristoph Roderburg, Nicole do O, Roland Fuchs, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|September 18, 2007
Regenerative capacity differs between micro- and macrovesicular hepatic steatosisAgnieszka Oleszczuk, Michael Spannbauer, Andrea Tannapfel, et al.
Pageof 1